Feedback
Settings

Settings

Goto Application

1. CA3056222 - A DRUG FOR THE EFFECTIVE CONTROL OF ACUTE AND/OR CHRONIC PAIN AND A METHOD FOR ITS ADMINISTRATION

PermaLink
Office
Canada
Application Number 3056222
Application Date 13.04.2017
Publication Number 3056222
Publication Date 19.10.2017
Grant Number
Grant Date 29.09.2020
Publication Kind C
IPC
A61K 38/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
07Tetrapeptides
A61P 25/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
04Centrally acting analgesics, e.g. opioids
C07K 5/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
10Tetrapeptides
CPC
A61K 38/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
07Tetrapeptides
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
C07K 5/1016
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
10Tetrapeptides
1002with the first amino acid being neutral
1016and aromatic or cycloaliphatic
A61K 9/0019
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
A61K 9/1611
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1611Inorganic compounds
A61K 9/1617
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1605Excipients; Inactive ingredients
1617Organic compounds, e.g. phospholipids, fats
Applicants PVP LABS PTE. LTD.
Inventors VYACHESLAV STANISLAVOVICH KOSORUKOV
EVGENY STANISLAVOVICH RZHANINOV
NIKOLAI VASILIEVICH KOROBOV
Priority Data 2016133329 12.08.2016 RU
10201602973W 14.04.2016 SG
Title
(EN) A DRUG FOR THE EFFECTIVE CONTROL OF ACUTE AND/OR CHRONIC PAIN AND A METHOD FOR ITS ADMINISTRATION
(FR) MEDICAMENT POUR LA PRISE EN CHARGE EFFICACE D'UNE DOULEUR AIGUE ET/OU CHRONIQUE ET SON PROCEDE D'ADMINISTRATION
Abstract
(EN) The invention relates to medicine and veterinary applications, in particular, as a means for effective control of acute and/or chronic pain, and may be used in emergency medicine for the treatment of acute and/or chronic pain, including the late stages of cancer. The stated means is based on a compound for preventing and/or treating acute or chronic pain in a subject, comprising an analgesic peptide having an amino acid sequence H-Tyr-D-Arg-Phe-Gly-NH2 or an amino acid sequence H-Tyr-D-Arg-Phe-Sar-OH. Also, a method of use of the compound for the prevention and/or treatment of acute and/or chronic pain is disclosed.
(FR) La présente invention concerne des applications médicales et vétérinaires, en particulier, en tant que moyen de lutte efficace contre une douleur aiguë et/ou chronique, et peut être utilisée en médecine d'urgence pour le traitement d'une douleur aiguë et/ou chronique, comprenant les stades tardifs d'un cancer. Le moyen décrit est basé sur un composé pour prévenir et/ou traiter une douleur aiguë ou chronique chez un sujet, comprenant un peptide analgésique ayant une séquence d'acides aminés H-Tyr-D-Arg-Phe-Gly-NH2 ou une séquence d'acides aminés H-Tyr-D-Arg-Phe-Sar-OH. L'invention concerne en outre un procédé d'utilisation du composé pour la prévention et/ou le traitement d'une douleur aiguë et/ou chronique.
Related patent documents
SG10201602973W
RU0002622980
US20180221432
CN108697758
EP3442557
WO/2017/180064
DK3442557
PT3442557
ES2930757
LT3442557
RS63779
PL3442557
HRP20221395
IN201817038518
# -